Increased Serum Concentration of Circulating Soluble Receptor for Interleukin-2 and Its Effect as a Prognostic Indicator in Cachectic Patients with Gastric and Colorectal Cancer

Publisher： Karger

E-ISSN： 1423-0232|56|1|54-58

ISSN： 0030-2414

Source： Oncology, Vol.56, Iss.1, 1999-01, pp. : 54-58

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Serum Level of a Soluble Receptor for Interleukin-2 as a Prognostic Factor in Patients with Gastric Cancer

By  

Oncology, Vol. 56, Iss. 3, 1999-04 ,pp. : 253-258

Karger

Access to resources Recommend Favorite

Soluble CD44 Variant 6 as a Prognostic Indicator in Patients with Colorectal Cancer

By  

Oncology, Vol. 56, Iss. 3, 1999-04 ,pp. : 232-238

Karger

Access to resources Recommend Favorite

Serum Soluble Interleukin-2 Receptor in Eosinophilia

By  

Acta Haematologica, Vol. 109, Iss. 1, 2002-12 ,pp. : 23-28

Karger

Access to resources Recommend Favorite

Macroscopic Borrmann Type as a Simple Prognostic Indicator in Patients with Advanced Gastric Cancer

By  

Oncology, Vol. 77, Iss. 3-4, 2009-09 ,pp. : 197-204

Karger

Access to resources Recommend Favorite

A Prognostic Indicator of Survival in Metastatic Colorectal Cancer Patients in the Era of Molecular-Targeted Agents: The Modified Glasgow Prognostic Score

By  

Oncology, Vol. 86, Iss. 1, 2013-12 ,pp. : 44-45

Karger

Access to resources Recommend Favorite